Review Note

Last Update: 03/30/2025 10:02 PM

Current Deck: ACG Part 2::Plastic Surgery and Burns

New Card (Unpublished)

Currently Published Content


Front
Back

No published tags.

Pending Suggestions


Field Change Suggestions:
What is a free flap? Describe the general principles of the physiological changes with free flaps, and the peri-operative management of flap surgery.
What is a Free Flap?
  • A free flap is where a tissue is lifted from a donor site and moved to a recipient site with an intact blood supply, compared to a graft, which doesn’t have an intact blood supply and relies on the growth of new blood vessels.
  • Involves separation of the flap from the original vascular supply and microvascular reanastomosis at a distant site associated with substantial transient ischemia of the tissue.
  • Done to fill a defect from surgery/injury or to rebuild complex anatomic structures (e.g., breast or jaw).
  • A free flap is the highest level of surgical complexity on the "reconstructive ladder" and has anaesthetic implications to maximize flap survival.
  • Free flaps offer the best functional and cosmetic results but have a higher risk of failure due to:
    • Primary ischemia at the time of surgery.
    • Reperfusion injury and impaired post-op flow, leading to secondary ischemia.

Phases of Ischemia & Reperfusion

  • Primary Ischemia:
    • Cessation of blood flow causes anoxia.
    • Anaerobic metabolism leads to lactate accumulation, pH drop, ATP depletion, calcium increase, and pro-inflammatory mediators.
    • Tissues with a high metabolic rate are more susceptible (muscle > skin).
    • Ischemia duration depends on surgical time (60-90 mins).
  • Reperfusion:
    • Begins when vascular clamps are released.
    • Normally restores blood flow and reverses physiological derangement.
    • Prolonged ischemia or poor perfusion pressure increases the risk of reperfusion injury.
    • Reperfusion injury occurs when inflammatory substrates enter and destroy the flap.
  • Secondary Ischemia:
    • Occurs post-transplantation if the flap suffers massive intravascular thrombosis and interstitial oedema.
    • Flaps tolerate 10-12 hours of ischemia, but irreversible changes occur at 4 hours.
  • Failure Rates:
    • Most failures occur within the first 48 hours post-op due to venous thrombosis (more common than arterial occlusion).
    • Overall success rate = ~90%.
  • Causes of Failure:
    • Arterial: Inadequate anastomosis, spasm, or thrombosis.
    • Venous: Defective anastomosis, spasm, or compression (poor positioning or tight dressings).
    • Oedema: Excessive crystalloid administration, trauma, or prolonged ischemia (flaps lack lymphatics, making them prone to oedema).
  • Vascular Response:
    • Transplanted vessels lack sympathetic innervation but respond to local and humoral factors (e.g., circulating catecholamines).

Common Free Flap Types

  • Latissimus Dorsi Flap Muscle/musculocutaneous for large soft tissue defects.
  • Scapular Flap Fascial, fasciocutaneous, or osteocutaneous (mandible/maxilla reconstruction).
  • TRAM Flap (Rectus Abdominis) Muscle/musculocutaneous (used in glossectomy, orbit, skull base, breast reconstruction).
  • Fibula Graft Osseous/osteocutaneous (head & neck bony defects).
  • DIEP Flap (Deep Inferior Epigastric Perforator) Musculocutaneous (breast reconstruction).
  • Radial Forearm Flap Fascia+skin or bone+skin (head and neck reconstruction).
  • Anterior Thigh Flap Fascia+skin ± muscle.
  • Gracilis Flap Facial reanimation/sphincter reconstruction.
  • Temporoparietalis Flap Fascia+skin (head and neck defects).
  • Omental Flap Vascularized fat.
  • Jejunal Flap Pharyngeal and oesophageal reconstruction (low ischemic tolerance).

Factors Influencing Perfusion

  • Blood flow through microcirculation depends on Starling forces (hydrostatic vs. oncotic pressure).
  • Flow follows Hagen-Poiseuille equation:

    • To maintain flow, optimize MAP, viscosity, and avoid vasoconstriction.
  • Regulation of Microcirculation:
    • Neural: SNS control of vascular tone.
    • Humoral: Catecholamines.
    • Local Factors:
      • Metabolic: Increased K+, H+, osmolarity, adenosine, CO₂ vasodilation.
      • Myogenic autoregulation: Constriction with high pressure, dilation with low pressure.
  • Effects of Surgery on Blood Flow:
    • GA increases platelet aggregation, RBC rigidity, clotting factors, and plasma fibrinogen, while impairing fibrinolysis.
    • Transfused blood is less deformable (low 2,3-DPG).

Perioperative Management

Pre-Op Considerations

  • Patient Assessment:
    • CVS status Can the patient tolerate high CO for prolonged periods?
    • Flap failure risk factors Smoking, diabetes, PVD.
  • Surgical Planning:
    • Assess donor/recipient site (e.g., previous radiotherapy = poor vessel quality).
    • Vascular Imaging (CTA) Ensures donor limb isn’t left ischemic.
  • Anaesthetic Factors:
    • Airway assessment, regional anaesthesia options, fluid management plan.
    • Need for arterial line, CVL, HDU/ICU post-op care.

Intraoperative Management

  • Optimizing Perfusion:
    • Maintain MAP, normothermia, and normocarbia.
    • Prevent vasoconstriction (adequate pain relief, fluid loading, avoiding vasopressors).
  • Anaesthesia Techniques:
    • Propofol TIVA Lowers SVR, antiemetic, inhibits platelet aggregation.
    • Remifentanil Blunts SNS response.
    • Regional Anaesthesia Enhances flap flow via vasodilation.
  • Fluids:
    • Excess crystalloid = oedema = venous thrombosis = flap failure.
    • Restrict crystalloids to pre-op deficits & intra-op losses.
    • Goal = modest hypervolemia:
      • 10-20mL/kg pre-op losses + 4-8mL/kg/hr intra-op insensible losses.
      • >6mL/kg/hr fluids = flap failure risk.
    • Colloids may be used for haemodilution (target Hct 30-35%).
  • Vasopressors:
    • No evidence of flap failure with low-dose vasopressors.
    • Consider beta-agonists (ephedrine, dobutamine) over pure alpha-agonists.
  • Avoid Transfusions Unless Necessary Transfused RBCs are less deformable.
  • Anticoagulation:
    • Prophylactic LMWH recommended to reduce graft failure.

Post-Op Care

  • Smooth Emergence Avoid coughing/straining (prevents tension on suture lines).
  • ICU/HDU monitoring First 48 hours are critical.
  • Flap Observations:
    • Pale, pulseless flap = arterial issue.
    • Swollen, dusky flap = venous congestion.
  • Pain Management:
    • Regional/Epidural ideal, PCA, paracetamol.
    • Avoid NSAIDs for first 48 hrs (risk of bleeding).
  • Early LMWH Introduction Reduces thrombosis risk.
  • Low threshold for surgical re-exploration if compromise suspected.